Viewing Study NCT05345002


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-05-28 @ 8:29 PM
Study NCT ID: NCT05345002
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2022-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Sponsor: Stephen Bagley, MD, MSCE
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioma View
None IDH Mutation View
None Astrocytoma View
None Oligodendroglioma View
Keywords: